Moving Biotech secures FDA Fast Track for 4P004 targeting knee osteoarthritis with synovitis after failure of at least two ...
The US FDA and CMS have launched the RAPID pathway to accelerate Medicare coverage for certain breakthrough medical devices by aligning regulatory and reimbursement processes earlier in development.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果